CME Group Inc.
CME
$285.75
$3.171.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 15.33% | 8.63% | -3.04% | 11.31% | 10.66% |
| Total Other Revenue | 1.77% | -0.37% | -2.44% | -2.47% | 6.22% |
| Total Revenue | 14.44% | 7.99% | -3.00% | 10.37% | 10.35% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 14.44% | 7.99% | -3.00% | 10.37% | 10.35% |
| SG&A Expenses | 9.65% | 13.45% | 3.09% | 6.85% | 1.95% |
| Depreciation & Amortization | 0.97% | -1.20% | -1.55% | -0.95% | -3.28% |
| Other Operating Expenses | -12.02% | -43.43% | -16.60% | 7.28% | 0.97% |
| Total Operating Expenses | 6.61% | 4.33% | 0.74% | 5.65% | 1.03% |
| Operating Income | 18.20% | 10.18% | -5.04% | 12.86% | 15.46% |
| Income Before Tax | 21.38% | 43.94% | 0.01% | 15.23% | 11.80% |
| Income Tax Expenses | 23.56% | 78.15% | 1.86% | 12.50% | 11.77% |
| Earnings from Continuing Operations | 20.72% | 35.25% | -0.53% | 16.07% | 11.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.72% | 35.25% | -0.53% | 16.07% | 11.81% |
| EBIT | 18.20% | 10.18% | -5.04% | 12.86% | 15.46% |
| EBITDA | 17.01% | 9.26% | -4.77% | 11.79% | 13.93% |
| EPS Basic | 23.80% | 35.21% | -0.60% | 15.96% | 11.71% |
| Normalized Basic EPS | 21.48% | 43.57% | -0.07% | 15.12% | 11.69% |
| EPS Diluted | 21.30% | 35.00% | -0.40% | 16.12% | 11.49% |
| Normalized Diluted EPS | 20.38% | 43.53% | -0.11% | 15.07% | 11.68% |
| Average Basic Shares Outstanding | -0.08% | 0.02% | 0.08% | 0.09% | 0.10% |
| Average Diluted Shares Outstanding | 0.83% | 0.05% | 0.12% | 0.14% | 0.11% |
| Dividend Per Share | 4.00% | 8.70% | 8.70% | 8.70% | 8.70% |
| Payout Ratio | -0.13% | -0.20% | 0.09% | -0.06% | -0.01% |